Skip to main content
OpenTrials

Clinical trial condition

Narcolepsy

Explore clinical trials studying Narcolepsy. Study availability and eligibility vary by location and protocol.

116 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Narcolepsy trial results

Completed

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

NCT04923594

Conditions
Cataplexy Narcolepsy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Sleep Medicine Center Redwood City, California, United States
  • Pacific Research Network San Diego, California, United States
  • St. Francis Sleep Allergy and Lung Institute Clearwater, Florida, United States
View all 22 locations
View Trial Details
Completed

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

NCT02720744

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • University Sleep Disorder Center Auburn, Alabama, United States
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
View all 57 locations
View Trial Details
Completed

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

NCT01624480

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Teva Investigational Site 12 Birmingham, Alabama, United States
  • Teva Investigational Site 17 Birmingham, Alabama, United States
  • Teva Investigational Site 7 Little Rock, Arkansas, United States
  • Teva Investigational Site 18 Orange, California, United States
View all 24 locations
View Trial Details
Completed

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

NCT01485770

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Pulmonary Associates Phoenix, Arizona, United States
  • Clinical Research Group of St. Petersburg St. Petersburg, Florida, United States
  • Neurotrials Research, Inc. Atlanta, Georgia, United States
  • Sleep Disorders Center of Georgia Atlanta, Georgia, United States
View Trial Details

Related conditions